Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
0.1465
-0.0135 (-8.44%)
At close: Nov 18, 2026, 4:00 PM EST
0.1485
+0.0020 (1.37%)
After-hours: Nov 18, 2026, 7:07 PM EST
Mangoceuticals Revenue
Mangoceuticals had revenue of $69.50K in the quarter ending September 30, 2026, a decrease of -17.50%. This brings the company's total for the last twelve months to $300.48K, down -35.64% year-over-year. In the year 2025, Mangoceuticals had annual revenue of $456.02K, down -25.96%. That makes Mangoceuticals the 45,093rd largest company in the world by revenue and 6,492nd in the United States.
Revenue (ttm)
$300.48K
Revenue Growth
-35.64%
P/S Ratio
10.84
Revenue / Employee
$100,161
Employees
3
Market Cap
3.26M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 456.02K | -159.85K | -25.96% |
| Dec 31, 2024 | 615.87K | -115.62K | -15.81% |
| Dec 31, 2023 | 731.49K | 722.55K | 8,083.16% |
| Dec 31, 2022 | 8.94K | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| LifeMD | 189.24M |
| CareCloud | 131.30M |
| Healthcare Triangle | 31.30M |
| DarioHealth | 21.30M |
| Mobile-health Network Solutions | 7.74M |
| Zhongchao | 6.61M |
| SCWorx | 2.93M |
| OneMedNet | 1.46M |
MGRX News
- 1 day ago - Mangoceuticals Proxy statement: Proxy filing - Filings
- 2 days ago - Mangoceuticals Quarterly report: Q3 2026 - Filings
- 6 days ago - Mangoceuticals to offer up to $10M of tokenized Series D preferred stock - TheFly
- 6 days ago - Mangoceuticals Partners with T7X to Become the First Nasdaq-Listed Company to Offer Tokenized Preferred Stock on the T7X Platform - GlobeNewsWire
- 12 days ago - Mangoceuticals Proxy statement: Proxy filing - Filings
- 6 weeks ago - Mangoceuticals reports $2.5M strategic investment in MangoRx IP Holdings - TheFly
- 6 weeks ago - Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche - GlobeNewsWire
- 3 months ago - Nuclea Energy, Enters into Definitive Agreement to Acquire Moltex Energy's Advanced Nuclear Technology Assets - Newsfile Corp